Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) ▲ | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| AbbVie Inc. | 43 | 0 | 21 | 0 | €154.58 | €176.30 | 14.052% |
| Zoetis Inc. A | 24 | 1 | 1 | 0 | €161.72 | €198.11 | 22.503% |
| Nektar Therapeutics | 4 | 1 | 1 | 0 | €1.17 | €2.40 | 104.604% |
| Corcept Therapeutics Inc. | 15 | 0 | 2 | 0 | €27.01 | €36.17 | 33.929% |
| Exact Sciences | 19 | 0 | 5 | 0 | €40.58 | €75.00 | 84.833% |
| Acadia Pharmaceuticals | 30 | 1 | 2 | 0 | €15.56 | €31.00 | 99.315% |
| Rigel Pharmaceutical Inc. | 14 | 0 | 3 | 0 | €0.74 | €13.82 | 1767.203% |
| Biogen Inc. | 58 | 1 | 8 | 0 | €210.80 | €291.35 | 38.209% |
| Amgen Inc. | 34 | 0 | 11 | 0 | €289.50 | €305.58 | 5.553% |
| Immunogen Inc. | 4 | 0 | 0 | 0 | €28.97 | - | - |
| Regeneron Pharmaceuticals Inc. | 51 | 1 | 14 | 0 | €980.00 | €1,049.8 | 7.119% |
| Ionis Pharmaceuticals Inc. | 20 | 5 | 0 | 0 | €43.25 | €56.72 | 31.148% |
| Vertex Pharmaceuticals Inc. | 58 | 2 | 11 | 0 | €450.00 | €459.80 | 2.178% |
| Gilead Sciences Inc | 23 | 1 | 12 | 0 | €62.16 | €75.00 | 20.656% |
| Anika Therapeutics | 5 | 0 | 0 | 0 | €23.60 | €28.29 | 19.876% |
| Biocryst Pharmaceuticals | 9 | 0 | 0 | 0 | €5.97 | €11.05 | 85.169% |
| Neurocrine Bioscience | 33 | 0 | 2 | 0 | €133.05 | €140.87 | 5.875% |
| Geron Corp. | 16 | 0 | 2 | 0 | €4.20 | €5.57 | 32.636% |
| Sarepta Therapeutics | 11 | 0 | 10 | 0 | €137.05 | €180.00 | 31.339% |
| United Therapeutics | 22 | 0 | 3 | 0 | €300.00 | €289.92 | -3.360% |
| BioMarin Pharmaceutical Inc. | 20 | 0 | 1 | 0 | €77.02 | €103.66 | 34.586% |
| Dynavax Technologies Corp | 3 | 0 | 1 | 0 | €10.27 | €27.02 | 163.189% |
| Exelixis Inc. | 19 | 0 | 1 | 0 | €20.17 | €26.01 | 28.936% |
| Innoviva Inc. | 4 | 0 | 1 | 0 | €15.20 | €30.00 | 97.368% |
| Cytokinetics Inc. | 34 | 1 | 2 | 0 | €51.00 | €83.92 | 64.541% |